We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| AcelRX Pharmaceuticals Inc | NASDAQ:ACRX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.86 | 0.861 | 0.89 | 0 | 01:00:00 |
Exhibit 24
Information Regarding Joint Filers
Designated Filer of Form 4: Perceptive Advisors LLC
Date of Earliest Transaction Required to be Reported: November 17, 2015
Issuer Name and Ticker Symbol: AcelRX Pharmaceuticals, Inc. (ACRX)
| Names: | Perceptive Life Sciences Master Fund Ltd. and Joseph Edelman |
| Address: | Perceptive Advisors LLC |
| 499 Park Avenue, 25th Floor | |
| New York, NY 10022 |
Signatures:
The undersigned, Perceptive Life Sciences Master Fund Ltd. and Joseph Edelman, are jointly filing the attached Statement of Changes in Beneficial Ownership of Securities on Form 4 with Perceptive Advisors LLC with respect to the beneficial ownership of securities of AcelRX Pharmaceuticals, Inc.
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD.
By: Perceptive Advisors LLC, its investment manager
By: /s/ Joseph Edelman
Joseph Edelman, managing member
JOSEPH EDELMAN
By: /s/ Joseph Edelman
Joseph Edelman
1 Year AcelRX Pharmaceuticals Chart |
1 Month AcelRX Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
